Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
The purpose of this research project is to develop fundamental technologies for elucidation of the nature of Reston ebolavirus (REBOV) infection. I analyzed genome sequences of REBOV detected from cynomolgus monkeys in the Philippines and designed novel primer/probes for a real-time PCR method to detect REBOV infection. This method is evaluated using RNA samples obtained from REBOV infected monkeys. For a serological testing, I developed competitive ELISA for detecting serum anti-REBOV antibody using REBOV-NP specific monoclonal antibody. In addition, the REBOV-GP expression system was established. It might be a useful material for developing anti-GP monoclonal antibodies.
|